NORTHERN BIOLOGICS INC.
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Its therapeutic antibody candidates are derived from a state-of-the-art phage display platform developed and refined by world-leading researchers at the University of Toronto, and we focus on developing novel functional modulators of key signaling pathways in cancer and fibrosis. Northern Biologics was founded in 2014 and headquartered in Toronto, Ontario, Canada.
NORTHERN BIOLOGICS INC.
Social Links:
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.northernbiologics.com
Total Employee:
11+
Status:
Closed
Contact:
(416)634-7132
Email Addresses:
[email protected]
Total Funding:
7.29 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL Oracle Cloud NSONE
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-12-01 | Mosaic Biomedicals | Mosaic Biomedicals acquired by Northern Biologics Inc. | N/A |
Investors List
Sixty Degree Capital
Sixty Degree Capital investment in Venture Round - Northern Biologics Inc.
Official Site Inspections
http://www.northernbiologics.com
- Host name: a74e89cf4458da039.awsglobalaccelerator.com
- IP address: 52.223.13.41
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Northern Biologics Inc."
Northern Biologics Inc Company Profile | Toronto, ON, Canada ...
Find company research, competitor information, contact details & financial data for Northern Biologics Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Versant Ventures | Northern Biologics
Northern Biologics was the first company built through the Blueline Bioscience incubator, and serves as a case study about the necessary ingredients to turn academic science and entrepreneurial insights into a viable biotech start-up …See details»
Northern Biologics 2025 Company Profile: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Northern Biologics. Use the PitchBook Platform to explore the full profile.See details»
Northern Biologics - Ownership and Business Overview | Mergr
May 14, 2020 Northern Biologics, Inc. is a clinical-stage company with a vision to discover, develop, and advance first-in-class antibody therapeutics to improve patient outcomes in cancer.See details»
Northern Biologics Start-up - UHN Research
Northern Biologics is the first spin-out company from Blueline Biosciences, a Canadian biotechnology incubator backed by Versant Ventures. It was developed using a “build-to-buy” …See details»
Northern Biologics - Company Profile - Tracxn
Feb 1, 2025 Northern Biologics develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company has acquired the MSC-1 (phase I trials) antibody for targeting …See details»
Northern Biologics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Northern Biologics, Inc. with its drug pipeline, therapeutic area, technology platform, 9 news, and 5 literature, Disease Domain:Neoplasms, Technology ...See details»
Northern Biologics Company Profile - Office Locations ... - Craft
See insights on Northern Biologics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Northern Biologics - VentureRadar
"Northern Biologics is a clinical stage company launched in Toronto in late 2014 with a vision to discover, develop and advance first-in-class antibody therapeutics to improve patient …See details»
Northern Biologics Company Overview, Contact Details
Learn more about Northern Biologics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Northern Biologics - Products, Competitors, Financials, Employees ...
Northern Biologics develops therapeutic antibodies for the treatment of human diseases in oncology and fibrosis. On May 18, 2020, Northern Biologics was acquired by Boehringer …See details»
UHN spin-off company part of big deal in cancer therapeutics
May 14, 2020 Northern Biologics was founded in 2014 through the biggest biotech deal in Canada at the time. It was created based on licenses for intellectual property developed by …See details»
Northern Biologics Inc. - Contacts, Employees, Board ... - Crunchbase
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.See details»
Northern Biologics: new biotech company to develop cancer drugs
It's a biotech company sprung from research by University of Toronto Professor Sachdev Sidhu and backed by the San Francisco-based venture capital firm Versant Ventures. The goal: to …See details»
Boehringer Ingelheim acquires Northern Biologics Inc. - 2020-05 …
May 14, 2020 Northern Biologics Inc. Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.See details»
NORTHERN BIOLOGICS US INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NORTHERN BIOLOGICS US INC of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Northern Biologics Strengthens Management Team - BioSpace
Aug 1, 2018 “Northern Biologics has recently made an important transition into a clinical-stage immuno-oncology company. In addition to a promising lead candidate, MSC-1, in Phase I …See details»
BI Expands Immuno-oncology Portfolio | Boehringer Ingelheim US
BI announces the acquisition of Northern Biologics Inc., which focuses on therapeutic antibodies targeting the tumor microenvironment.See details»
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical …
May 14, 2020 Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor …See details»
Polpharma Biologics announces approval of Europe’s first and only ...
Sep 26, 2023 Amsterdam, The Netherlands, 26th September 2023 Polpharma Biologics, an international biotech company dedicated to the development and manufacturing of biosimilars, …See details»